AbbVie
Search results
Allergan is now part of AbbVie. We discover and develop innovative medicines for tomorrow, while helping people live better lives today.
Allergan plc was formed in March 2015 when Irish–registered Actavis plc acquired U.S.–registered Allergan, Inc., and assumed the Allergan name. In 2016, Allergan sold its generic drugs business, Actavis, to Teva Pharmaceuticals for $40.5 billion.
Allergan Aesthetics develops, manufactures, and markets a portfolio of leading brands and products including facial injectables, body contouring, plastics, skin care, and more. Skip to Main Content
May 8, 2020 · AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced today that it has completed its acquisition of Allergan plc following receipt of regulatory approval from all...
Advantage is your online destination to access your favorite Allergan Aesthetics programs, product information, marketing materials, training resources and more. Sign up We create the products and technologies that drive the advancement of aesthetic medicine and empower confidence in practices, staff, and patients every day.
Allergan is now part of AbbVie We discover and develop innovative medicines for tomorrow, while helping people live better lives today. Our products
Allergan, Inc. was an American global pharmaceutical company focused on eye care, neurosciences, medical dermatology, medical aesthetics, breast enhancement, obesity intervention and urologics. Allergan, Inc. was formed in 1948, incorporated in 1950 and became a public company in 1970. [2]
